Patient attitudes and understanding about biosimilars: an international cross-sectional survey
about
Assessing gastroenterologist and patient acceptance of biosimilars in ulcerative colitis and Crohn's disease across GermanyCT-P13 in the treatment of rheumatoid arthritis.Looking to the future and learning lessons from the recent past: changing stakeholder perceptions of biosimilars in cancer.Assessing physician and patient acceptance of infliximab biosimilars in rheumatoid arthritis, ankylosing spondyloarthritis and psoriatic arthritis across Germany.Medical specialists' attitudes to prescribing biosimilars.Improving Access to Cancer Treatments: The Role of Biosimilars.Treatment Outcomes with Biosimilars: Be Aware of the Nocebo Effect.Policies for biosimilar uptake in Europe: An overview.Perception of Originator Biologics and Biosimilars: A Survey Among Belgian Rheumatoid Arthritis Patients and Rheumatologists.Reviewing the evidence for biosimilars: key insights, lessons learned and future horizons.Patients' Understanding and Attitudes Towards Infliximab and Etanercept Biosimilars: Result of a UK Web-Based Survey.Assessment of structural and functional similarity of biosimilar products: Rituximab as a case study.A bibliometric analysis of the global research on biosimilars.Food and Drug Administration guidances on biosimilars: an update for the gastroenterologistNon-pharmacological Effects in Switching Medication: The Nocebo Effect in Switching from Originator to Biosimilar Agent
P2860
Q36347183-EF83A32D-CB36-4D2D-8618-8ABDA2CC1377Q38676104-F3C0B172-F47C-4F21-B57F-A2D53973A5C5Q38686396-68C23F65-4DD9-46A8-BA42-C35E9524A341Q38885209-60348787-4326-4636-B4CD-65D1B561D811Q38944652-38C659D5-2228-42DC-833D-364640C427E6Q47099597-E9591C88-FD5F-4381-93C4-59AC45375253Q47106974-29ED2385-9407-4465-8B52-BFBF303BB1F8Q47173303-F18CDC72-F90C-4284-A26E-F9F8FD8D9FD5Q47656264-9E63FA4A-DA49-4E20-83E9-23E043931EEAQ47807650-18A5CBFF-FBB6-498B-B698-82C96A2DFAD0Q48332377-1596CAE3-4416-469E-8A63-CF320843601AQ50098437-DE2E1720-2C3D-47BD-A29A-9D1B87E2E883Q55239713-7B82BEBB-A1C6-4839-A2B5-710E4062AAD5Q57298239-29C1104C-9A3C-4CC8-B5B9-7AB413E21F2BQ58795531-5E4E5C1E-5E24-4314-AE02-20140BE2AD45
P2860
Patient attitudes and understanding about biosimilars: an international cross-sectional survey
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Patient attitudes and understa ...... ational cross-sectional survey
@en
type
label
Patient attitudes and understa ...... ational cross-sectional survey
@en
prefLabel
Patient attitudes and understa ...... ational cross-sectional survey
@en
P2093
P2860
P356
P1476
Patient attitudes and understa ...... ational cross-sectional survey
@en
P2093
Ahmad Al-Sabbagh
Ira Jacobs
K Lea Sewell
Lesley G Shane
P2860
P304
P356
10.2147/PPA.S104891
P407
P577
2016-05-26T00:00:00Z